Zilia, a Quebec City, Canada-based medical technology company, raised an undisclosed amount in bridge funding.
Backers included Linearis Ventures.
The company intends to use the funds to scale commercialization of its flagship technology, the Zilia Ocular.
Led by CEO Patrick Sauvageau, Zilia is a medical technology company developing a platform to non-invasively measure biomarkers in the eye, with an initial focus on ocular oximetry. By integrating photonics and artificial intelligence, its technology is intended to leverage the eye’s optical properties and direct connections to the vascular system and the brain, capturing critical information on ocular and overall health.
FinSMEs
07/05/2025